Hassanzadeh-Taheri Mohammadmehdi, Salimi Mojtaba, Vazifeshenas-Darmiyan Khadijeh, Mohammadifard Mahtab, Hosseini Mehran
Cellular and Molecular Research Center, Department of Anatomical Sciences, Faculty of Medicine, Birjand University of Medical Sciences, Birjand, Iran.
Cellular and Molecular Research Center, Department of Biochemistry, Birjand University of Medical Sciences, Birjand, Iran.
J Diabetes Metab Disord. 2021 Sep 23;20(2):1573-1581. doi: 10.1007/s40200-021-00904-1. eCollection 2021 Dec.
Management of hepatorenal complications in diabetic patients is still a challenge for clinicians. The study aimed to investigate the impacts of ethanolic extract of (Nees) Engl.oleo-gum-resin (EEM) against hepatorenal injury in diabetic rats.
Diabetes was induced by an intraperitoneal (i.p.) injection of streptozotocin (55 mg/kg) in adult male Wistar rats (n = 40); whereas, normal control rats (NC, n = 8) were treated with vehicle solution (citrate buffer, i.p.). Diabetic animals were gavaged with 500 mg/kg of metformin (MET500) and different doses of EEM (100, 300, and 500 mg/kg) once daily for 28 days. Diabetic model (DM) and NC groups were treated with normal saline. Various parameters like fasting blood glucose (FBG), plasma insulin, aspartate transaminase (AST), alanine transaminase (ALT), creatinine (Cr), urea, 24-h urine total protein (UTP), urine volume, and hepatorenal histopathology were assessed at the end of the study.
Compared to the NC group, diabetic rats showed marked elevations in FBG, AST, ALT, urea, Cr, UTP, urine volume, and a significant reduction in insulin. Diabetic animals also exhibited severe histopathological alterations in liver and kidney tissues. The EEM treatment could not influence the biochemical and pathological alterations. Treatment with EEM at the dose of 300 mg/kg could slightly ameliorate some pathological alterations (fatty changes and tubular congestion) in hepatic and renal tissues.
These findings demonstrated that EEM treatment at doses up to 500 mg/kg could not effectively slow down the pathological process of hepatorenal damage in diabetic rats.
糖尿病患者肝肾并发症的管理对临床医生而言仍是一项挑战。本研究旨在探讨(Nees)Engl.油胶树脂(EEM)乙醇提取物对糖尿病大鼠肝肾损伤的影响。
通过腹腔注射链脲佐菌素(55毫克/千克)诱导成年雄性Wistar大鼠(n = 40)患糖尿病;而正常对照大鼠(NC,n = 8)用赋形剂溶液(柠檬酸盐缓冲液,腹腔注射)治疗。糖尿病动物每天灌胃500毫克/千克二甲双胍(MET500)和不同剂量的EEM(100、300和500毫克/千克),持续28天。糖尿病模型(DM)组和NC组用生理盐水治疗。在研究结束时评估各种参数,如空腹血糖(FBG)、血浆胰岛素、天冬氨酸转氨酶(AST)﹑丙氨酸转氨酶(ALT)、肌酐(Cr)、尿素、24小时尿总蛋白(UTP)、尿量以及肝肾组织病理学。
与NC组相比,糖尿病大鼠的FBG、AST、ALT、尿素、Cr、UTP、尿量显著升高,胰岛素显著降低。糖尿病动物的肝和肾组织也表现出严重的组织病理学改变。EEM治疗未能影响生化和病理改变。300毫克/千克剂量的EEM治疗可略微改善肝和肾组织中的一些病理改变(脂肪变性和肾小管充血)。
这些发现表明,高达500毫克/千克剂量的EEM治疗不能有效减缓糖尿病大鼠肝肾损伤的病理过程。